Found: 58
Select item for more details and to access through your institution.
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.840651
- By:
- Publication type:
- Article
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. 1, doi. 10.3389/fnagi.2021.712545
- By:
- Publication type:
- Article
Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1868, doi. 10.1002/alz.13607
- By:
- Publication type:
- Article
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD Multimodal Biomarker Discovery study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080072
- By:
- Publication type:
- Article
Whole‐exome rare‐variant analysis of Alzheimer's disease and related biomarker traits.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2317, doi. 10.1002/alz.12842
- By:
- Publication type:
- Article
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 807, doi. 10.1002/alz.12713
- By:
- Publication type:
- Article
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 1, p. 29, doi. 10.1002/alz.12365
- By:
- Publication type:
- Article
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 10, p. 1628, doi. 10.1002/alz.12330
- By:
- Publication type:
- Article
Replication study of plasma proteins relating to Alzheimer's pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 9, p. 1452, doi. 10.1002/alz.12322
- By:
- Publication type:
- Article
CSF proteomic profiling of mild cognitive impairment individuals with suspected non‐Alzheimer's disease pathophysiology: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047247
- By:
- Publication type:
- Article
Synaptic proteins relate to memory scores in preclinical Alzheimer's disease and cognitively healthy controls depending on amyloid: Molecular and cell biology/synaptic disruption.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046102
- By:
- Publication type:
- Article
DNA methylation differences associated with peripheral biomarkers in the EMIF‐AD cohort: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045853
- By:
- Publication type:
- Article
Amyloid pathology, but not vascular pathology, is associated with risk of incident dementia in non‐demented memory clinic participants: Neuroimaging: Neuroimaging predictors of cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045196
- By:
- Publication type:
- Article
Neurofilament light and cognitive performance: Associations with amyloid and vascular pathologies in individuals with mild cognitive impairment: Biomarkers (non‐neuroimaging): EEG and other biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042739
- By:
- Publication type:
- Article
Identification of plasma proteome signatures associated with ATN framework using SOMAscan: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.036954
- By:
- Publication type:
- Article
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 11, p. 1478, doi. 10.1016/j.jalz.2019.06.4951
- By:
- Publication type:
- Article
Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 9, p. 1149, doi. 10.1016/j.jalz.2019.04.015
- By:
- Publication type:
- Article
O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1626, doi. 10.1016/j.jalz.2019.06.4860
- By:
- Publication type:
- Article
P4‐525: ASSOCIATION OF CSF TAU WITH HYPERPLASTICITY IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1515, doi. 10.1016/j.jalz.2019.08.072
- By:
- Publication type:
- Article
P2‐242: PATHOPHYSIOLOGICAL SUBTYPES OF ALZHEIMER'S DISEASE BASED ON CEREBROSPINAL FLUID PROTEOMICS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P675, doi. 10.1016/j.jalz.2019.06.2649
- By:
- Publication type:
- Article
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 7, p. 888, doi. 10.1016/j.jalz.2019.04.001
- By:
- Publication type:
- Article
Inflammatory biomarkers in Alzheimer's disease plasma.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 776, doi. 10.1016/j.jalz.2019.03.007
- By:
- Publication type:
- Article
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 6, p. 817, doi. 10.1016/j.jalz.2019.03.004
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 5, p. 644, doi. 10.1016/j.jalz.2019.01.004
- By:
- Publication type:
- Article
P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1161, doi. 10.1016/j.jalz.2018.06.1592
- By:
- Publication type:
- Article
P2‐458: PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P895, doi. 10.1016/j.jalz.2018.06.1151
- By:
- Publication type:
- Article
P2‐270: INCREASED CSF AMYLOID‐β 1‐38 AND 1‐40 CONCENTRATIONS IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT WITH TAU BUT WITHOUT AMYLOID PATHOPHYSIOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P780, doi. 10.1016/j.jalz.2018.06.959
- By:
- Publication type:
- Article
O2‐15‐04: ROBUST INDIVIDUALIZED PREDICTION MODELS WHICH ARE APPLICABLE ACROSS DIFFERENT COHORTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P661, doi. 10.1016/j.jalz.2018.06.2727
- By:
- Publication type:
- Article
F1‐02‐04: GENOMICS AND EPIGENOMICS ANALYSES IN THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P204, doi. 10.1016/j.jalz.2018.06.2310
- By:
- Publication type:
- Article
F1‐02‐03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P202, doi. 10.1016/j.jalz.2018.06.2309
- By:
- Publication type:
- Article
F1‐02‐02: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER'S DISEASE PROGRESSION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P201, doi. 10.1016/j.jalz.2018.06.2308
- By:
- Publication type:
- Article
F1‐02‐01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT‐LIGHT AND YKL‐40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P201, doi. 10.1016/j.jalz.2018.06.2307
- By:
- Publication type:
- Article
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
- Published in:
- Translational Psychiatry, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41398-020-01074-z
- By:
- Publication type:
- Article
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00628-z
- By:
- Publication type:
- Article
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0428-1
- By:
- Publication type:
- Article
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0396-5
- By:
- Publication type:
- Article
Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0328-9
- By:
- Publication type:
- Article
DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P361, doi. 10.1016/j.jalz.2017.06.305
- By:
- Publication type:
- Article
DURATION OF ALZHEIMER’S DISEASE IN THE PRECLINICAL, PRODROMAL AND DEMENTIA STAGE: A MULTI-STATE MODEL ANALYSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P585, doi. 10.1016/j.jalz.2017.07.212
- By:
- Publication type:
- Article
CHARACTERIZATION OF SUSPECTED NON-ALZHEIMER’S DISEASE PATHOPHYSIOLOGY (SNAP) IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT USING NEUROIMAGING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P414, doi. 10.1016/j.jalz.2017.06.403
- By:
- Publication type:
- Article
EUROPEAN MEDICAL INFORMATION FRAMEWORK FOR ALZHEIMER’S DISEASE (EMIF-AD): THE BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P691, doi. 10.1016/j.jalz.2017.06.864
- By:
- Publication type:
- Article
ASSOCIATIONS BETWEEN VASCULAR RISK FACTORS AND AD BIOMARKERS IN COGNITIVELY NORMAL INDIVIDUALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1506, doi. 10.1016/j.jalz.2017.07.621
- By:
- Publication type:
- Article
DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P174, doi. 10.1016/j.jalz.2017.07.016
- By:
- Publication type:
- Article
PREVALENCE OF VASCULAR RISK FACTORS IN DIFFERENT STAGES OF PRODROMAL ALZHEIMER’S DISEASE AND ITS INFLUENCE ON COGNITIVE DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1059, doi. 10.1016/j.jalz.2016.06.2213
- By:
- Publication type:
- Article
Creating normative values for cognitive tests in amyloid positive and amyloid negative cognitively normal subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P131, doi. 10.1016/j.jalz.2015.07.044
- By:
- Publication type:
- Article
Longitudinal assessment of health-related quality of life after SARS-CoV-2 infection and the associations with clinical and social characteristics in a general practice population.
- Published in:
- Health & Quality of Life Outcomes, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12955-024-02301-7
- By:
- Publication type:
- Article
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01233-z
- By:
- Publication type:
- Article
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. N.PAG, doi. 10.3389/fnagi.2018.00193
- By:
- Publication type:
- Article
Detection of primary Sjögren's syndrome in primary care: developing a classification model with the use of routine healthcare data and machine learning.
- Published in:
- BMC Primary Care, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12875-022-01804-w
- By:
- Publication type:
- Article